Localizing safety performance functions for two-way STOP-controlled (TWST) three-leg intersections on rural two-lane two-way (TLTW) roadways in Alabama: A geospatial modeling approach with clustering analysis.

Accid Anal Prev

Department of Civil, Construction and Environmental Engineering, The University of Alabama, Tuscaloosa, AL 35487, United States; Alabama Transportation Institute, The University of Alabama, Tuscaloosa, AL 35487, United States.

Published: January 2023

Safety Performance Functions (SPFs) can be used to predict the number of crashes for highway facilities by site characteristics, including traffic exposures and other specific site factors. The traditional approach to developing SPFs relies on factors that are observed in the data and has an unstated assumption that the relationships between safety performance and observed factors are stationary. However, there might be factors that are not captured by the data but also have significant impacts on roadway safety performance. These factors can lead to significant unobserved heterogeneity in safety performance at different sites. Failure to capture such unobserved heterogeneity in developing SPFs may result in biases and decrease the predictive accuracy. Given the interactions between highway traffic and roadway environments, the unobserved heterogeneity is likely related to the geographic space of the highway network. This study employs a spatial modeling approach, namely Geographically Weighted Negative Binomial Regression (GWNBR), to incorporate spatial heterogeneity into SPF model estimation. The GWNBR model can generate a local SPF for every site instead of a global SPF for one entire jurisdiction (e.g., a state) from the traditional approach. Local SPFs (or l-SPFs) are high-resolution and may be difficult for practitioners to use. To support the implementation of l-SPFs, this study proposes a method to aggregate l-SPFs to various geographic levels. This study first uses the 2014-2018 geo-referenced crash data from Alabama to develop l-SPFs for two-way STOP-controlled (TWST) three-leg intersections on rural two-lane two-way (TLTW) roadways in the state. The results show that l-SPFs vary substantially across Alabama. For example, the coefficients of traffic volume (AADT) on major roads range from 0.126 to 1.203 across different areas of the state. Then, an aggregation method based on K-means clustering is demonstrated to aggregate l-SPFs to various geographic levels of interest. The l-SPFs and their aggregation provide geographic flexibility in developing countermeasures and allocating funds to improve traffic safety considering local conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.aap.2022.106896DOI Listing

Publication Analysis

Top Keywords

safety performance
20
unobserved heterogeneity
12
performance functions
8
two-way stop-controlled
8
stop-controlled twst
8
twst three-leg
8
three-leg intersections
8
intersections rural
8
rural two-lane
8
two-lane two-way
8

Similar Publications

Objective: Clazosentan is a recently approved endothelin receptor antagonist indicated for the prevention of vasospasm and related complications following aneurysmal subarachnoid hemorrhage (aSAH). To date, no direct, head-to-head comparison between clazosentan and nimodipine has been conducted. In this study, we indirectly assessed the efficacy and safety of these two drugs in preventing vasospasm and its associated outcomes after aSAH.

View Article and Find Full Text PDF

Background: Prostate cancer treatment involves hormonal therapies that may carry cardiovascular risks, particularly for long-term use. Gonadotropin-releasing hormone (GnRH) antagonists, such as degarelix, may offer advantages over agonists, but comprehensive comparative cardiovascular outcomes are not well established. This study aimed to systematically review and analyze the cardiovascular safety profiles of degarelix compared to those of traditional GnRH agonists, providing critical insights for optimizing treatment strategies.

View Article and Find Full Text PDF

Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial.

Lancet Diabetes Endocrinol

January 2025

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address:

Background: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA levels and new-onset diabetes are conflicting. We aimed to examine the effect of oral finerenone, compared with placebo, on incident diabetes in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF) trial.

Methods: In this randomised, double-blind, placebo-controlled trial, 6001 participants with heart failure with New York Heart Association functional class II-IV, left ventricular ejection fraction 40% or higher, evidence of structural heart disease, and elevated N-terminal pro-B-type natriuretic peptide levels were randomly assigned to finerenone or placebo, administered orally.

View Article and Find Full Text PDF

Exosomal miR-302b rejuvenates aging mice by reversing the proliferative arrest of senescent cells.

Cell Metab

January 2025

Henan Academy of Sciences, Zhengzhou 450000, China; Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China. Electronic address:

Cellular senescence, a hallmark of aging, involves a stable exit from the cell cycle. Senescent cells (SnCs) are closely associated with aging and aging-related disorders, making them potential targets for anti-aging interventions. In this study, we demonstrated that human embryonic stem cell-derived exosomes (hESC-Exos) reversed senescence by restoring the proliferative capacity of SnCs in vitro.

View Article and Find Full Text PDF

A rapidly growing number of chimeric antigen receptors (CARs) is being translated into cell therapy for malignant and autoimmune diseases. While cancer cell-selective CAR targeting is undergoing continuous refinement, specific testing for overlooked recognition of healthy tissues is commonly not performed, which potentially results in underestimating of the risk of severe tissue damage upon CAR T cell application. Using the FcμR/IgM receptor/FAIM3/TOSO-specific CAR, designed to target chronic lymphocytic leukemia cells, we exemplarily outline a screen to uncover reactivities to healthy tissues and discuss the value of such pre-clinical testing to improve safety in CAR T cell application.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!